Brief: HKEX Announces Disciplinary Action Against Fusen Pharmaceutical & Five Current Directors
04/01/2023 10:07
Jan 4 (Reuters) - Hong Kong Exchanges and Clearing Ltd
0388.HK :
* ANNOUNCES DISCIPLINARY ACTION AGAINST FUSEN PHARMACEUTICAL
CO
AND FIVE CURRENT DIRECTORS
Further company coverage: 0388.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA